Medrobotics® Corporation Receives FDA Clearance for Flex® Robotic System for Scarfree™ Colorectal Procedures

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

Medrobotics’ Flex® Robotic System was designed to provide an affordable, easy-to-use and highly mobile robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients. Minimally invasive surgery has demonstrated advantages for patients and providers, such as shorter hospital stays and faster recovery times.

Medrobotics Corp., a medical robotics company, announced today it has received FDA regulatory clearance to market the Flex® Robotic System for colorectal procedures in the United States. Medrobotics is the first and only company to offer minimally invasive, steerable and shapeable robotic products for colorectal procedures in the U.S. The Flex® Robotic System is the world’s first robotic surgical platform to offer Scarfree™ access to hard-to-reach anatomy in otolaryngology and colorectal procedures. This provides surgeons treatment options that may not be possible with straight, rigid instruments.

CEO Samuel Straface, Ph.D highlighted, “The human gastrointestinal system is full of twists and turns, and rigid surgical robots were not designed to operate in that environment. The Flex® Robotic System was. Two years ago Medrobotics started revolutionizing treatment in the head and neck in the U.S. We can now begin doing that in colorectal procedures. American hospitals, surgeons and patients will be able to enjoy the benefits of the world’s only flexible, surgical robotic platform. It will easily integrate into hospitals due to its mobility and short learning curve.”

Dr. Alessio Pigazzi, Professor of Surgery at the University of California, Irvine said, “The Flex® Robotic System offers the promise to treat select colorectal patients transanally with a more consistent and an easier approach because it overcomes the limits of straight surgical instrumentation.  Medrobotics is ushering in the first of a new generation of shapeable and steerable robotic surgical systems that offer the potential to reduce the invasiveness of surgical procedures for more patients.”

Minimally invasive, Flex® Robotic System offers surgeons the unique ability to navigate complex anatomy through a single, small entry point to operate in difficult-to-reach places. Today, access is gained through the mouth and anus. In future applications, access may be obtained through other natural orifices such as the vagina, or through small incisions in the abdomen.

The company notes they are developing new surgical applications for its core platform technology in the areas of general surgery, gynecology, and urology, among others. These new applications are not yet cleared for use in the U.S.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.